PHARMA NEWS

Stelis Pharma

Stelis Pharma to supply Sputnik V for India

Stelis Pharma partners with Russia’s sovereign wealth fund to supply 200 million doses of Sputnik V for India Stride Pharma’s subsidiary Stelis Biopharma has partnered with Russia’s sovereign wealth fund regarding Sputnik V production. This collaboration aims to produce and supply over 200 million doses of the COVID – 19 vaccines for India. Strides Pharma

Stelis Pharma to supply Sputnik V for India Read More »

pharma products recall

Pharma Products recall from the US Market

Sun Pharma, Dr. Reddy’s Laboratories, Aurobindo Pharma, and Jubilant Pharma recall products in the US market : Sun Pharma, Aurobindo Pharma, Dr. Reddy’s Laboratories, and Jubilant Pharma have begun to recall products in the US market. These companies initiated the aforementioned action due to various reasons. The USFDA’s[1] latest Enforcement report stated that Sun Pharma

Pharma Products recall from the US Market Read More »

Strides Pharma’s potassium chloride

USFDA approves Strides Pharma’s potassium chloride

USFDA approves Strides Pharma’s potassium chloride oral solution for marketing in the US Strides Pharma’s step-down subsidiary has recently received the USFDA’s[1] approval for one of its products. The US health regulator approved the company’s potassium chloride for oral solution. This news was shared by Strides Pharma Global, Singapore, on 15 March 2021 [1]. Potassium

USFDA approves Strides Pharma’s potassium chloride Read More »

Cipla Gulf expands partnership with Alvotech

Cipla Gulf expands partnership with Alvotech

Cipla’s Gulf subsidiary expands partnership with Alvotech to market four drugs in Australia and New Zealand:  Cipla’s Gulf subsidiary has decided to expand its partnership with Alvotech [1] . The partnership is to commercialize four drugs in Australia and New Zealand, as announced on 2 March 2021. This move aims to facilitate the marketing and distribution

Cipla Gulf expands partnership with Alvotech Read More »

Scroll to Top